This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Aligos Therapeutics, Inc.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of David McGowan
Introduction
David McGowan is an accomplished inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on bicyclic compounds. His research and inventions have the potential to impact the treatment of various diseases and conditions.
Latest Patents
David McGowan holds a patent for bicyclic compounds, which includes compounds of Formula (I) and their pharmaceutically acceptable salts. This patent also encompasses pharmaceutical compositions that incorporate these compounds and methods for synthesizing them. Furthermore, it outlines methods for treating diseases and conditions using these innovative compounds.
Career Highlights
David McGowan is currently associated with Aligos Therapeutics, Inc., where he continues to advance his research and development efforts. His work at Aligos Therapeutics has positioned him as a key player in the pharmaceutical industry, focusing on innovative solutions for healthcare challenges.
Collaborations
Some of David's notable coworkers include Sandrine Vendeville and Yannick Debing. Their collaborative efforts contribute to the dynamic research environment at Aligos Therapeutics, fostering innovation and progress in the field.
Conclusion
David McGowan's contributions to the field of pharmaceuticals through his patent on bicyclic compounds exemplify his commitment to innovation. His work not only enhances the understanding of these compounds but also paves the way for new treatment options in medicine.